drugset / Trial / NCT05776953

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

NCT05776953

Phase 4 Recruiting 86 enrolled Hackensack Meridian Health
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Timeline

Start
2023-12-21
Primary completion
2026-09-01
Completion
2026-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 15 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous